Evidence map›Paper›PMID 34958143›Full record

ArticlePrenatal diagnosis2022

Trio exome sequencing is highly relevant in prenatal diagnostics.

Heinz Gabriel, Dirk Korinth, Martin Ritthaler, Björn Schulte, Florian Battke, Constantin von Kaisenberg, Max Wüstemann, Bernt Schulze, Almuth Friedrich-Freksa, Lutz Pfeiffer and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Prenatal diagnosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. De NovoInternational journal of molecular sciences · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

Heinz GabrielPraxis für Humangenetik Tübingen, Tübingen, Germany.
Dirk KorinthPraxis für Humangenetik Tübingen, Tübingen, Germany.
Martin RitthalerPraxis für Humangenetik Tübingen, Tübingen, Germany.
Björn SchultePraxis für Humangenetik Tübingen, Tübingen, Germany.
Florian BattkeCeGaT GmbH, Tübingen, Germany.ORCID 0000-0001-6021-5837
Constantin von KaisenbergKlinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover, Hannover, Germany.
Max WüstemannZentrum für Pränatalmedizin Hannover, Hannover, Germany.
Bernt SchulzeMedicover Humangenetik Hannover, Hannover, Germany.
Almuth Friedrich-FreksaInstitut für Klinische Genetik Mainz, Mainz, Germany.
Lutz PfeifferMedicover Humangenetik Berlin-Lichtenberg, Berlin, Germany.
Michael EntezamiZentrum für Pränataldiagnostik, Berlin, Germany.
Andreas SchröerZentrum für Pränataldiagnostik, Berlin, Germany.
Joachim BürgerLimbach Humangenetik Berlin, Berlin, Germany.
Eva Maria Christina SchwaiboldInstitut für Humangenetik, Universitätsklinikum Heidelberg, Heidelberg, Germany.
Holger LebekPränatale Diagnostik Berlin-Lichtenberg, Berlin, Germany.
Saskia BiskupPraxis für Humangenetik Tübingen, Tübingen, Germany.
Praxis für Humangenetik Tübingen · DEZentrum für Pränataldiagnostik · DECeGaT (Germany) · DEGenetikum · DEHeidelberg University · DEMedicover · DEMedizinische Hochschule Hannover · DEPathodiagnostik Berlin · DEPraxis für Humangenetik · DESana Klinikum Lichtenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAbout 3% of newborns show malformations, with about 20% of the affected having genetic causes. Clarification of genetic diseases in postnatal diagnostics was significantly improved with high-throughput sequencing, in particular through whole exome sequencing covering all protein-coding regions. Here, we aim to extend the use of this technology to prenatal diagnostics.

methodBetween 07/2018 and 10/2020, 500 pregnancies with fetal ultrasound abnormalities were analyzed after genetic counseling as part of prenatal diagnostics using WES of the fetus and parents.

resultsMolecular genetic findings could explain ultrasound abnormalities in 38% of affected fetuses. In 47% of these, disease-causing de novo variants were found. Pathogenic variants in genes with autosomal recessive or X-linked inheritance were detected in more than one-third (70/189 = 37%). The latter are associated with increased probability of recurrence, making their detection important for further pregnancies. Average time from sample receipt to report was 12 days in the recent cases.

conclusionTrio exome sequencing is a useful addition to prenatal diagnostics due to its high diagnostic yield and short processing time (comparable to chromosome analysis). It covers a wide spectrum of genetic changes. Comprehensive interdisciplinary counseling before and after diagnostics is indispensable.

Indexed as

ExomeUltrasonography, PrenatalExome SequencingFemaleFetusHumansInfant, NewbornPregnancyPrenatal Diagnosis

Identifiers

PMID34958143
PMCPMC9305182
OpenAlexW4200098525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.